Actively Recruiting
App and Body Fat Scale in the Management of Overweight Patients
Led by Capital Medical University · Updated on 2025-06-05
204
Participants Needed
1
Research Sites
108 weeks
Total Duration
On this page
Sponsors
C
Capital Medical University
Lead Sponsor
M
Merck Sharp & Dohme LLC
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study tests whether using a health app (Huawei Health) and a smart body fat scale can help overweight patients with schizophrenia or bipolar disorder lose weight and stay engaged in their health. What We're Testing: 1. Patients who use the app and scale for 4 months (Group 1) will lose more weight than those who use them for 2 months (Group 2). 2. Patients who track their weight, diet, and exercise regularly (≥3 times/week) will lose more weight than those who don't. 3. Seeing weight loss results may motivate patients to keep using the app and scale. How It Works: Patients weigh themselves weekly with the scale (auto-syncs to the app) and upload dietary log in Huawei Health app. The app will gives personalized diet/exercise tips and tracks progress. Doctors and nutritionists provide extra support through messages. Goal: To see if this digital tool + professional support combo works better for long-term weight management.
CONDITIONS
Official Title
App and Body Fat Scale in the Management of Overweight Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 to 60 years with no gender restriction
- Diagnosed with bipolar disorder or schizophrenia according to ICD-10 and currently in remission or stable condition
- Currently using at least one antipsychotic or mood stabilizer medication
- Overweight or obese with body mass index (BMI) ≥ 24 kg/m2 and willing to use health app and smart scales to lose weight
- Education level of primary school or above, able to understand the scale content and proficient in smartphone use
- Understand and voluntarily agree to participate and provide informed consent
You will not qualify if you...
- Planning to lose weight by other methods during the study (dieting, inducing vomiting, diet pills, surgery)
- Self-reported weight loss ≥ 7% in the past 6 months
- Weight over 150 kg
- Secondary obesity due to other causes (e.g., hypothyroidism, Cushing's syndrome, hypothalamic obesity)
- Currently pregnant, lactating, less than 6 months postpartum, or planning pregnancy during the study
- Self-reported cardiac discomfort or chest pain during activity or rest
- Serious medical condition posing safety risk with physical activity
- Unable to walk 30 minutes without stopping
- Conditions affecting protocol compliance (e.g., end-stage disease, planned travel, substance abuse, uncontrolled medical conditions)
- Any other condition deemed inappropriate by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Beijing Anding Hospital
Beijing, Beijing Municipality, China
Actively Recruiting
Research Team
L
Le Xiao
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here